Even modest meds adherence can be financially transformative for health systems
Dr. Colin Banas, chief medical officer at DrFirst

Even modest meds adherence can be financially transformative for health systems

While medication adherence is a cornerstone of value-based care, it depends on the right team, tools and targeted patient engagement to be effective, says one chief medical officer.

As healthcare continues to advance with accountable care organizations and value-based care models, the industry is starting to see some real traction after a decade of groundwork in the form of CMS claims for the Medicare Shared Savings Program.

There are some critical elements driving success here. The role of medication adherence and patient engagement are pivotal factors for continuing to achieve ACO and VBC goals. And even modest improvements in medication adherence can drive significant economic impacts for health systems.

Dr. Colin Banas, chief medical officer at DrFirst, a medication management technology company, says these strategies translate into real-world benefits from the "prescriptions perspective." We spoke with him recently to better understand some of the progress being made.

CLICK HERE TO READ THE COMPLETE STORY

要查看或添加评论,请登录

Bill Siwicki的更多文章

社区洞察

其他会员也浏览了